Chief scientist okays 13 new projects

The software sector dominated the budget as seven projects were approved for an investment of NIS 4.7m. from the budget of the chief scientist and a total investment scope of NIS 11m.

By AVI KRAWITZ
November 27, 2006 08:39

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The research committee of the Office of the Chief Scientist has approved 13 new research & development projects for which the Chief Scientist will finance NIS 8.7 million from its budget, the Ministry of Industry, Trade and Labor said Sunday. The total investment volume of the projects amount to NIS 19.7m., the ministry said. The software sector dominated the budget as seven projects were approved for an investment of NIS 4.7m. from the budget of the chief scientist and a total investment scope of NIS 11m. Two communications project received approval as did two medical equipment projects, one in electronics and one in an unnamed field.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS